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Abstract
Introduction: The disconnection hypothesis of Alzheimer’s disease (AD) is supported by growing neuroimaging
and neurophysiological evidence of altered brain functional connectivity in cognitively impaired individuals.
Brain functional modalities such as [18F]fluorodeoxyglucose positron-emission tomography ([18F]FDG-PET)
and electroencephalography (EEG) measure different aspects of synaptic functioning, and can contribute to un-
derstanding brain connectivity disruptions in AD.
Aim: This study investigated the relationship between cortical glucose metabolism and topographical EEG mea-
sures of brain functional connectivity in subjects along AD continuum.
Methods: Patients diagnosed with mild cognitive impairment (MCI) and AD (n = 67), and stratified into
amyloid-positive (n = 32) and negative (n = 10) groups according to cerebrospinal fluid Ab42/40 ratio, were
assessed with [18F]FDG-PET and resting-state EEG recordings. EEG-based neuroimaging analysis involved
standardized low-resolution electromagnetic tomography (sLORETA), which estimates functional connectivity
from cortical sources of electrical activity in a 3D head model.
Results: Glucose hypometabolism in temporoparietal lobes was significantly associated with altered EEG
functional connectivity of the same regions of interest in clinically diagnosed MCI and AD patients and in
patients with biomarker-verified AD pathology. The correlative pattern of disrupted connectivity in tempor-
oparietal lobes, as detected by EEG sLORETA analysis, included decreased instantaneous linear connectivity
in fast frequencies and increased lagged linear connectivity in slow frequencies in relation to the activity of
remaining cortex.
Conclusions: Topographical EEG measures of functional connectivity detect regional dysfunction of
AD-vulnerable brain areas as evidenced by association and spatial overlap with the cortical glucose hypometab-
olism in MCI and AD patients.
Keywords: Alzheimer’s disease; electroencephalography; [18F]fluorodeoxyglucose-PET; functional connectivity;
standardized low-resolution electromagnetic tomography (sLORETA)
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Impact Statement
The association between glucose hypometabolism, as evidenced by [18F]FDG-PET ([18F]fluorodeoxyglucose positron-
emission tomography), and altered electroencephalography (EEG) functional connectivity metrics within temporoparietal
lobes provides link between synaptic, neurophysiological, and metabolic impairment in mild cognitive impairment and
Alzheimer’s disease patients. This study reported alterations in EEG measures of both instantaneous and lagged linear
connectivity across distinct frequency bands, both of which were shown to be important for inter- and intrahemispheric
communication and function of memory systems in general. EEG-based imaging of brain functional connectivity has a po-
tential to serve as a noninvasive, low-cost, and widely available alternative in assessing synaptic and network dysfunction
in cognitively impaired patients.
Introduction
The disconnection hypothesis of Alzheimer’s disease(AD) has emerged as a result of the growing neuroimag-
ing and neurophysiological evidence of altered brain func-
tional connectivity in cognitively impaired individuals
(Delbeuck et al., 2003). This notion has been substantiated
by neuropathological findings in AD patients, including
widespread propagation of AD pathological hallmarks,
such as amyloid-beta (Ab) and tau deposits, damage and
loss of synapses, and large corticocortical connections in
the brain (Corder et al., 2000; Delbeucket al., 2003; Uylings
and de Brabander, 2002). Other evidence that supports this
hypothesis includes initial accumulation of Ab, the main cul-
prit of the disease according to the prevailing amyloid hy-
pothesis (Selkoe and Hardy, 2016), in regions that exhibit
changes in brain connectivity in preclinical AD as evidenced
by functional magnetic resonance imaging (fMRI) (Palmqvist
et al., 2017). These findings encourage the investigation of
disturbances in resting-state brain connectivity as a potential
biomarker of AD. In addition, AD develops on a clinical and
biological continuum, including clinically asymptomatic in-
dividuals, subjects with subjective impairment, patients with
mild cognitive impairment (MCI) and AD dementia, and is
characterized by a typical cascade of dynamic biomarker
changes (Sperling et al., 2011). However, neuropathological
and neuroimaging markers, the latter including both conven-
tional and novel molecular imaging methods, pose either
delayed (postmortem) or costly diagnostic alternatives.
High temporal resolution of the electroencephalography
(EEG) technique, which directly measures brain synaptic ac-
tivity, makes it convenient for investigating synchrony of
the underlying large-scale neuronal populations. Numerous
studies have already reported disturbances in EEG functional
connectivity early during the course of AD, supporting the hy-
pothesis of a disconnection syndrome. The most consistent
findings that aroused from the global scalp EEG signal analy-
sis include decreased both instantaneous (Koenig et al., 2005;
Smailovic et al., 2018) and lagged connectivity measures
(Stam et al., 2007) in fast frequency bands in patients along
AD continuum. Referred disturbances in the EEG connectivity
measures were associated with the degree of cognitive impair-
ment and molecular markers of AD in the cerebrospinal fluid
(CSF) (Engels et al., 2015; Ma et al., 2014; Smailovic et al.,
2018). Even though these global scalp EEG measures summa-
rize substantial amount of data, have straightforward computa-
tion and a user-friendly interpretation, they lack localization
properties.
Functional imaging techniques such as standardized low-
resolution electromagnetic tomography (sLORETA), on the
contrary, estimate 3D distribution of cortical sources of EEG
rhythms in a human head model and can be used for investiga-
tion of regional disturbances in brain functional connectivity
(Pascual-Marqui et al., 1994). Electrical neuroimaging is there-
fore a potential technique for early and longitudinal assessment
of changes in brain connectome during AD pathogenesis.
In addition to EEG and fMRI, resting-state network dys-
function has been proposed by [18F]fluorodeoxyglucose
positron-emission tomography ([18F]FDG-PET) imaging in
MCI and AD patients (Pagani et al., 2017a; Toussaint
et al., 2012). However, in the clinical settings, [18F]FDG-
PET is mainly used to estimate topographical distribution
of resting-state glucose utilization in the brain. Decreased
glucose metabolism in the temporoparietal regions is the
most consistent [18F]FDG-PET finding and a supportive
marker of possible AD (Mosconi, 2005). Previous studies
have shown that the referred pattern of glucose hypometab-
olism correlates with the degree of cognitive deficits and is
predictive of future transition to AD dementia in patients
with MCI (Chetelat et al., 2003; Desgranges et al., 1998;
Herholz et al., 2002; Pagani et al., 2017b).
Both EEG and [18F]FDG-PET are functional modalities
that provide information on synaptic activity, by mirroring
direct summation of excitatory and inhibitory postsynaptic
potentials and indirect metabolic demands of the neurons, re-
spectively. However, studies investigating complementarity
of these two modalities as topographical markers of neuronal
and synaptic dysfunction, the latter being an early event and
best correlate of cognitive deficits in AD patients (Terry
et al., 1991), are still scarce. A correlation between the spa-
tial indices of brain glucose metabolism and the localization
of the brain electrical center of gravity has been reported
(Dierks et al., 2000), as well as an association between the
index of cortical glucose hypometabolism and EEG delta ac-
tivity when analyzed in the same regions of interest (ROIs),
comprised of frontal association, ventromedial frontal, tem-
poroparietal, posterior cingulate, and precuneus areas, as
assessed by EEG LORETA analysis (Babiloni et al., 2016).
Nevertheless, relationship between the regional glucose
hypometabolism and the topography of altered brain func-
tional connectivity evidenced by EEG is yet to be investi-
gated in the context of AD.
The main aim of this study was to investigate whether
EEG measures of functional connectivity may provide simi-
lar information as [18F]FDG-PET on selective regional dys-
function of vulnerable brain areas in patients along AD
continuum and with biomarker-verified AD molecular pa-
thology. In contrast to the prior approaches, EEG functional
connectivity metrics employed in this study were estimated
by sLORETA, and included measures of both instantaneous
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and lagged linear connectivity in four conventional fre-
quency bands. We hypothesized that both measures might
provide comprehensive information on regional cortical dis-
connection associated with AD-related processes such as de-
creased glucose metabolism in temporoparietal lobes.
Methods
Study population
The study included 67 memory clinic patients clinically di-
agnosed with MCI (n = 41) and AD (n = 26). All patients under-
went comprehensive clinical assessment starting with physical
and neurological examination and neuropsychological testing,
and were recruited at Karolinska University Hospital Hud-
dinge, Sweden. The clinical diagnoses of MCI or AD were
established according to the Winblad and colleagues (2004)
and ICD-10 criteria (World Health Organization, 1992), re-
spectively. At the following consensus diagnostic round, re-
sults of computed tomography (CT) or MRI brain imaging
and conventional CSF biomarker analysis (where available)
were taken into account when establishing final diagnosis.
[18F]FDG-PET imaging and resting-state EEG recordings
were additionally performed to exclude other possible dif-
ferential diagnoses.
This study evaluated, as a first part, the relationship be-
tween EEG and [18F]FDG-PET in a sample of initially
clinically diagnosed MCI and AD patients. As a second
step, the relationship between the two modalities was de-
termined in a subsample of patients with biomarker con-
firmed amyloid pathology.
For the second part of the study analysis, 42 patients (24
MCI and 18 AD) who underwent lumbar puncture and had fro-
zen CSF available from the biobank were stratified according
to their amyloid status. For the purpose of this study, CSF
Ab42/40 ratio was additionally analyzed as it compensates
for between-individual differences in ‘‘total’’ CSF Ab (using
Ab40 as a proxy), and it was shown to have a better diagnostic
performance than Ab42 measurement alone (Hansson et al.,
2007; Lewczuk et al., 2015). Based on their amyloid status
(cutoff for a positive CSF Ab42/40 ratio <0.89), 14 of 24
MCI were reclassified as amyloid-positive MCI or ‘‘MCI
due to AD.’’ Ten MCI subjects were amyloid negative and
were not included in the second correlative [18F]FDG-PET–
EEG analysis. All of the clinically diagnosed AD patients
with available CSF sample (n = 18) were amyloid positive
according to the CSF Ab42/40 ratio. In total, 32 amyloid-
positive, including ‘‘MCI due to AD’’ (n = 14) and AD
(n = 18), patients were included in the second part of the
study analyses.
Demographics together with MMSE data in clinical MCI
and AD and amyloid-positive and negative patient groups
are summarized in Table 1. The exclusion criteria included
presence of major psychiatric or neurological comorbidity,
epilepsy, psychotropic medication with effect on EEG, alco-
hol abuse, and time gap between [18F]FDG-PET and EEG re-
cording >6 months.
The study was conducted in accordance with Declaration
of Helsinki, and written informed consent was obtained from
all participants. This study was approved by the Local ethical
committee of the Karolinska Hospital and Regional Ethical
Review Board in Stockholm (Dnr: 2011/1978-31/4, 2020-
00678).
CSF sampling and analysis
The CSF was obtained from a subset of patients by a routine
lumbar puncture procedure (between the L3/L4 or L4/L5 inter-
vertebral space) using a 25-gauge needle and collected in
12 mL polypropylene tubes. The samples were then centri-
fuged at 1000 rpm for 10 min, divided into 1 mL aliquots,
and frozen at 70C. CSF Ab42/40 ratio was analyzed
using Meso Scale Discovery electrochemiluminescence
assay (Vplex; MSD). The cutoff for CSF Ab42/40 ratio pos-
itivity was <0.89.
[18F]FDG-PET data acquisition and analysis
All patients underwent PET/CT scan (Biograph mCT Sie-
mens, Knoxville, TN) as part of the clinical assessment at the
Division of Nuclear Medicine, Karolinska University Hospi-
tal Huddinge. [18F]FDG-PET is performed as a 10–15 min
scan 30–45 min after intravenous injection of 2–3 MBq/kg
weight. PET acquisition was performed with all appropriate
corrections as described previously in detail (Leuzy et al.,
2019).
Images was viewed and processed using Syngo.via program
(Siemens, Germany). The data were extracted using ‘‘MI Neu-
rology’’ workflow, including automatic template-based spatial
normalization and calculation of mean [18F]FDG standard-
ized uptake value ([18F]FDG-SUV) for 11 ROIs (10 compos-
ite cortical ROIs and the whole cerebellum ROI). Cortical
ROIs were merged to correspond to bilateral five main
brain lobes (frontal, parietal, occipital, temporal, and limbic
Table 1. Demographic and Clinical Characteristics of the Study Population
Clinical diagnosis (n = 67) Amyloid status (n = 42/67)
MCI AD pa Amyloid negative Amyloid positive pa
N 41 26 10 (all MCI) 32 (MCI+AD)
Age, years 68 (46–82) 63 (48–86) 0.403 63.5 (46–82) 67 (48–86) 0.652
Sex ratio, males/females 20/21 14/12 0.686 8/2 15/17 0.066
Education, years 13 (7–19) 14 (5–22) 0.766 14.5 (10–18) 11.5 (5–19) 0.202
MMSE 28 (23–30) 23.5 (7–30) <0.001 27 (24–30) 25 (7–30) 0.286
Data are presented as medians and full ranges (minimum–maximum). Amyloid status was based on CSF Ab42/20 ratio (the cutoff for CSF
Ab42/40 ratio positivity was <0.89).
ap-Values from the Mann–Whitney U test or chi-square as appropriate.
AD, Alzheimer’s disease; CSF, cerebrospinal fluid; MCI, mild cognitive impairment; MMSE, minimental state examination.
REGIONAL FUNCTIONAL DISCONNECTION IN ALZHEIMER’S DISEASE 557
lobe, which corresponded to the mesial temporal lobe in
Syngo software). ROIs were licensed from CEA/Groupe
d’Imagerie Fonctionnelle as published in automated anatom-
ical labeling atlas by Tzourio-Mazoyer and colleagues
(2002). [18F]FDG SUV ratios (SUVRs) were calculated for
each of 10 cortical ROIs using the whole cerebellum as a ref-
erence region to provide an overview of differences in brain
glucose metabolism in MCI and AD groups. In accordance
with the hypothesis of this study, the two most vulnerable
[18F]FDG-PET ROIs (bilateral parietal and temporal lobes)
were further correlated with EEG functional connectivity
measures in the corresponding brain regions.
EEG recordings and preprocessing
All patients underwent resting-state eyes-closed EEG re-
cording on the Nervus System (NicoletOne EEG Reader
v5.93.0.424; Natus NicoletOne, Pleasanton, CA) at the
Department of Clinical Neurophysiology, Karolinska Uni-
versity Hospital Huddinge. Nineteen scalp electrodes were
placed according to the standard 10/20 system. The pa-
tients’ vigilant states were monitored by a technician dur-
ing the whole EEG recording. The sampling rate of the
EEG recording was 256 Hz with the band-pass filters be-
tween 0.5 and 70 Hz and electrode impedance <5 kO.
The recording setup was described previously in detail by
Smailovic and colleagues (2018).
EEG data were preprocessed using (i) independent com-
ponent analysis algorithm for removal of ocular artifacts;
and (ii) visual inspection and manual artifact rejection for re-
moval of remaining artifacts and periods of eyes open and
nonresting-state vigilant states in Brain Vision Analyzer,
version 2.0 software (Gilching, Germany).
EEG sLORETA analysis
Preprocessed EEG data were further analyzed using sLOR-
ETA, which is one of the linear inverse solution techniques
that estimates 3D distribution of cortical sources of neuronal
activity that give rise to the scalp EEG data (Pascual-Marqui,
2002, 2007a). sLORETA was shown to have improved per-
formance compared with alternative linear inverse algorithms
(Pascual-Marqui, 1999) and has been previously validated
through studies that combined LORETA and structural and
fMRI, [18F]FDG-PET as well as intracranial electrode record-
ings (Dierks et al., 2000; Mulert et al., 2004; Worrell et al.,
2000; Zumsteg et al., 2006).
The sLORETA solution space is restricted to the MNI152
template that includes 6239 cortical gray matter voxels at the
resolution of 5 mm (Mazziotta et al., 2001). The MNI152 tem-
plate contains MNI coordinates with neuroanatomical labels
based on the ‘‘corrected’’ Talairach coordinates (Brett et al.,
2002). The current sources estimated by sLORETA can be av-
eraged across all voxels in a given ROI. In this study, sLORETA
ROI transformation matrix included five (bilateral) main brain
lobes (frontal, parietal, temporal, occipital, and limbic) that
were matched to the corresponding PET ROIs (Tzourio-
Mazoyer et al., 2002), with an exception of limbic lobe
that did not include hippocampus. The solution space was
restricted to the cortical gray matter since it is debatable
whether the activity of deep brain structures, such as hippo-
campus, can be correctly recorded and visualized by sLOR-
ETA in the context of correlative PET-EEG imaging study.
sLORETA is a functional imaging technique that can be
used to study brain functional connectivity between pairs of
ROI. In more detail, the tool named instantaneous linear con-
nectivity, as implemented in LORETA software, measures
statistical zero-lag linear dependence between cortical source
activities at a given frequency (Pascual-Marqui, 2007b). It is
important to note that EEG measures of instantaneous brain
connectivity should be interpreted with caution since they
are confounded by volume conduction effect, that is, zero-
lag spread of the electric fields from their source through the
tissue that leads to the nonphysiological inflation of the instan-
taneous connectivity measures. Still, these measures should
not be completely disregarded since physiological zero time-
lag synchronization was shown to be important for integrated
and coordinated neuronal communication between different
brain regions (Fell and Axmacher, 2011; Gollo et al., 2011;
Roelfsema et al., 1997). The second measure from LORETA
toolbox, named lagged linear connectivity, measures the sta-
tistical linear dependence between cortical source activities
after the instantaneous zero-lag contribution has been re-
moved, and therefore eliminates volume conduction effect
(Pascual-Marqui, 2007b; Pascual-Marqui et al., 2011). Lagged
linear connectivity measure, as estimated by LORETA soft-
ware, has been successfully employed in several EEG studies
on functional cortical connectivity in AD patients (Babiloni
et al., 2018a,b; Foresta et al., 2019).
In line with our hypothesis and their complementary physi-
ological implications, measures of both instantaneous and
lagged linear connectivity (Pascual-Marqui, 2007b) were com-
puted separately between each pair of (bilateral) temporal and
parietal lobe and all the remaining ROIs (main brain lobes).
Next, average instantaneous and lagged linear connectivity
were computed between each bilateral parietal and temporal
lobes and all of the remaining nine brain lobes. This resulted
in a measure of average instantaneous and lagged linear con-
nectivity of parietal and temporal lobes in relation to the ac-
tivity of the remaining cortex. Both instantaneous and lagged
linear connectivity measures were computed in the conven-
tional frequency bands, including delta (1–3.5 Hz), theta
(4–7.5 Hz), alpha (8–11.5 Hz), and beta (12–19.5 Hz) bands.
Statistical analysis
Statistical analysis was performed in SPSS (version 26;
IBM, NY). Nonparametric tests were used in all analyses
since the data of interest were not normally distributed. Dem-
ographics, MMSE, and [18F]FDG SUVRs were compared
between the groups using the Mann–Whitney U and chi-
square tests. The associations between brain glucose metab-
olism ([18F]FDG SUVR) and EEG sLORETA instantaneous
and lagged linear connectivity measures in temporoparietal
regions were investigated using Spearman’s rank correlation
tests. Since the analysis was exploratory, the results were
presented with both uncorrected and corrected p-values
(Benjamini–Hochberg correction with 5% false discovery
rate) for multiple comparisons. Significance threshold
value was p < 0.05 for all statistical tests.
Data availability statement
The datasets used and/or analyzed during this study are
available from the study’s senior and corresponding authors
on reasonable request.
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Results
Demographics
Demographic data and MMSE scores in clinically diag-
nosed MCI and AD patients and in amyloid-positive and
negative patient groups are presented in Table 1. There
were no statistically significant differences in age, sex, or ed-
ucation between the groups.
Brain glucose metabolism in MCI and AD patients
[18F]FDG-PET uptake in the brain was significantly dif-
ferent between clinically diagnosed MCI and AD patients
in bilateral frontal (left p = 0.010, U = 333, right p = 0.017,
U = 348), parietal (left p < 0.001, U = 202, right p < 0.001,
U = 189), and temporal lobes (left p < 0.001, U = 244, right
p = 0.001, U = 264) (Fig. 1). Consistent with the literature
(Mosconi, 2005), the most pronounced difference in brain
glucose metabolism was observed in temporoparietal lobes
( p £ 0.001) in the present patient cohort. In line with our
hypothesis, we have consequently focused on investigating
functional connectivity alterations of the referred vulnerable
brain regions (bilateral parietal and temporal lobes) in a cor-
relative [18F]FDG-PET and EEG sLORETA analyses.
Correlation between [18F]FDG-PET and EEG
sLORETA connectivity measures in clinically
diagnosed MCI and AD patients
In the first analysis, associations between brain glucose
metabolism and sLORETA instantaneous and lagged linear
connectivity in the corresponding temporal and parietal
lobes were assessed in the whole cohort of clinically diag-
nosed MCI and AD patients (n = 67).
Correlation analyses revealed significant associations be-
tween brain [18F]FDG SUVR and EEG instantaneous linear
connectivity in alpha and beta frequency bands in parietal
left (alpha: rs = 0.357, p = 0.003; beta: rs = 0.309, p = 0.011),
parietal right (alpha: rs = 0.289, p = 0.018; beta: rs = 0.335,
p = 0.006), temporal left (alpha: rs = 0.394, p = 0.001), and
temporal right lobes (alpha: rs = 0.369, p = 0.002) (Fig. 2a,
scatterplots presented in Supplementary Fig. S1). All correla-
tions remained significant after correcting for multiple com-
parisons (Benjamini–Hochberg correction), and their p-values
are shown in bold (Fig. 2a). In other words, decreased brain
glucose metabolism in temporoparietal lobes correlated with
decreased EEG instantaneous linear connectivity in fast fre-
quency bands when analyzed in the same ROIs.
On the contrary, brain [18F]FDG SUVR was significantly as-
sociated with lagged linear connectivity in delta and theta fre-
quency bands in parietal left (delta: rs =0.277, p = 0.023;
theta: rs =0.312, p = 0.010), parietal right (theta: rs =0.374,
p = 0.002), temporal left (theta: rs =0.351, p = 0.004), and tem-
poral right lobes (theta: rs =0.263, p = 0.032) (Fig. 2b, scatter-
plots presented in Supplementary Fig. S2). Correlations in the
right parietal and left temporal lobes remained significant after
correction for multiple comparisons, and their p-values are
shown in bold. Decreased brain glucose metabolism there-
fore correlated with increased EEG-lagged linear connectiv-
ity in slow frequency bands when analyzed in the same ROIs
(temporoparietal lobes) (Fig. 2b).
FIG. 1. Box-whisker plot of differences in [18F]FDG SUVR (y-axis) in five main brain lobes (x-axis) between MCI and AD
patients. Diagnostic groups are presented by different bar colors and outliers are shown as circles. Mann–Whitney U test over
the diagnostic groups; *p < 0.05, **p < 0.01, ***p < 0.001. AD, Alzheimer’s disease; [18F]FDG, [18F]fluorodeoxyglucose;
MCI, mild cognitive impairment; SUVR, standardized uptake value ratio.
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To complete investigation of the spatial overlap between
cortical glucose hypometabolism and altered brain func-
tional connectivity, associations between [18F]FDG SUVR
and sLORETA measures of instantaneous and lagged linear
connectivity in four conventional frequency bands were addi-
tionally assessed in frontal and occipital lobes. The correlative
analysis was not performed for the limbic lobe since sLOR-
ETA solution space was restricted to the cortical gray matter
and, in contrast to the corresponding PET ROIs, did not include
hippocampus. The measures of instantaneous and lagged linear
connectivity were computed in the same manner; that is, they
refer to the average connectivity of a localized region in rela-
tion to the rest of the functional network. In contrast to the tem-
poral and parietal lobes, relationship between glucose uptake
and EEG measures of functional connectivity in frontal and oc-
cipital lobes did not exhibit a consistent pattern of significant
associations in clinically diagnosed MCI and AD patients
nor in the subsample of CSF amyloid-positive patients (Sup-
plementary Tables S1–S4).
Correlation between [18F]FDG PET and EEG
sLORETA connectivity measures in CSF
amyloid-positive MCI and AD patients
In the second analysis, associations between brain glucose
metabolism and EEG sLORETA connectivity measures were
assessed in a group of amyloid-positive patients (n = 32,
according to CSF Ab42/40 ratio).
Correlation analyses revealed significant association be-
tween brain [18F]FDG SUVR and EEG instantaneous linear
connectivity in alpha and beta frequency bands in parietal
left (beta: rs = 0.492, p = 0.004), parietal right (beta: rs = 0.471,
p = 0.006), temporal left (alpha: rs = 0.484, p = 0.005), and tem-
poral right lobes (alpha: rs = 0.492, p = 0.004), when analyzed
in amyloid-positive patients only (Fig. 3a, scatterplots pre-
sented in Supplementary Fig. S3). All correlations remained sig-
nificant after correcting for multiple comparisons (Benjamini–
Hochberg correction), and their p-values are shown in bold
(Fig. 3a). The pattern of observed relationships was similar as
in the first analysis that included the entire cohort of MCI and
AD patients; decreased glucose metabolism correlated with de-
creased EEG instantaneous linear connectivity in fast frequency
bands in temporoparietal cortex.
On the contrary, brain [18F]FDG SUVR was significantly
associated with EEG-lagged linear connectivity in the right
temporal lobe only (theta band: rs =0.378, p = 0.033), when
analyzed in amyloid-positive patients; however, it did not sur-
vive correction for multiple comparison (Fig. 3b, scatterplots
presented in Supplementary Fig. S4).
There were no significant associations between [18F]FDG
SUVRs and sLORETA instantaneous nor lagged linear con-
nectivity in the temporal and parietal lobes when analyzed in
the group of amyloid-negative patients (consisting of MCI
patients, amyloid negative according to CSF Ab42/40 ratio)
(Supplementary Tables S5 and S6).
Discussion
This study investigated relationship between topography of
brain glucose metabolism and functional connectivity alter-
ations as evidenced by [18F]FDG-PET and EEG sLORETA
analysis, respectively, in patients along the AD continuum.
FIG. 2. Correlation between brain [18F]FDG SUVR and sLORETA instantaneous (a) and lagged (b) linear connectivity in
MCI and AD patients (n = 67). Colored areas represent the strength of the association (Spearman’s correlation coefficient)
between brain glucose metabolism and EEG measures of instantaneous and lagged linear connectivity in parietal L (left),
parietal R (right), temporal L (left), and temporal R (right) lobes in four conventional frequency bands. Spearman’s corre-
lation coefficients (up) and p-values (below, in brackets) of significant associations ( p < 0.05) are denoted on the plot,
while p-values that remained significant after Benjamini–Hochberg correction for multiple comparisons are shown in
bold. The red and blue colors indicate positive and negative correlations, respectively (as denoted on the color legend).
EEG, electroencephalography; sLORETA, standardized low-resolution electromagnetic tomography.
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Main findings of the study are as follows: brain glucose hypo-
metabolism in temporoparietal lobes, core [18F]FDG-PET
feature in AD, is associated with altered EEG functional con-
nectivity and functional ‘‘disconnection’’ of the same cortical
ROIs in clinically diagnosed MCI and AD patients and in a
subsample of patients with biomarker evidence of AD pathol-
ogy. The novelty of our study is that it demonstrated associ-
ations between glucose metabolism and EEG measures of
both instantaneous and lagged linear connectivity across dif-
ferent frequency bands, providing comprehensive informa-
tion on regional cortical disconnection associated with AD.
Cognitive processes are mediated by extensive functional
connection and interaction between localized and specialized
brain systems (Bressler and Menon, 2010). Therefore, local-
ized neuropathology and consequent dysfunction of vulnera-
ble brain areas, resembled by decreased metabolic (energetic
demand) of the neurons, may lead to the ‘‘communication
breakdown’’ among the affected brain regions. The patterns
of associations between brain glucose hypometabolism and
altered EEG connectivity measures in our study are similar
when analyzed in patients with CSF-verified amyloid pathol-
ogy compared with the group of patients clinically diagnosed
with MCI and AD. Moreover, there were no significant asso-
ciations between brain glucose metabolism and EEG connec-
tivity measures in the group of amyloid-negative patients.
The stratification was based on CSF Ab42/40 ratio, known
to correct for individual difference in amyloid production
and to have a superior diagnostic performance compared
with CSF Ab42 levels alone (Hansson et al., 2007; Lewczuk
et al., 2015). This aligns with the hypothesis of AD as a ‘‘dis-
connection syndrome’’ as the alterations in EEG functional
connectivity within disease-affected brain regions are pres-
ent in patients with the evidence of core AD molecular pa-
thology, that is, along genuine AD continuum.
Both instantaneous and lagged synchronization of neuro-
nal activity were shown to be physiologically important
for inter- and intrahemispheric communication and function
of memory systems in general (Fell and Axmacher, 2011;
Gollo et al., 2011; Roelfsema et al., 1997). Instantaneous
(zero-lag) synchronization between neuronal assemblies
may emerge as a result of simultaneous input from another
common brain region or through third relay station (Fell
and Axmacher, 2011). Furthermore, it has been shown that
zero-lag coupling can occur over distant brain regions due to
the neuronal mechanisms that can compensate for the axonal
delays (Traub et al., 1996; Bibbig et al., 2002). On the con-
trary, lagged synchronization presumably mirrors phase lag
between neuronal activity due to the conductive latencies
between brain regions (Fell and Axmacher, 2011). Our re-
sults further show that both of the referred measures of
brain functional connectivity may provide information on
brain network dysfunction due to AD pathology.
In more detail, brain glucose hypometabolism in left
and right parietal and temporal lobes correlated with de-
creased EEG instantaneous linear connectivity in fast fre-
quency bands (alpha and beta) when analyzed in the same
ROIs in MCI and AD patients. Fast frequency neuronal
synchronization has been shown to be implicated in exec-
utive and attentional functions as well as working and
long-term memory (Fell and Axmacher, 2011; Palva and
Palva, 2011). Numerous EEG measures of instantaneous
connectivity derived from the surface EEG data, such as
FIG. 3. Correlation between brain [18F]FDG SUVR and sLORETA instantaneous (a) and lagged (b) linear connectivity
in amyloid-positive MCI and AD patients (n = 32). Colored areas represent the strength of the association (Spearman’s
correlation coefficient) between brain glucose metabolism and EEG measures of instantaneous and lagged linear connec-
tivity in parietal L (left), parietal R (right), temporal L (left), and temporal R (right) lobes in four conventional frequency
bands. Spearman’s correlation coefficients (up) and p-values (below, in brackets) of significant associations ( p < 0.05)
are denoted on the plot, while p-values that remained significant after Benjamini–Hochberg correction for multiple com-
parisons are shown in bold. The red and blue colors indicate positive and negative correlations, respectively (as denoted on
the color legend).
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coherence and global field synchronization, have already
shown to decrease in fast frequencies in cognitively im-
paired patients, correlate with cognitive scores and AD
molecular markers (Smailovic and Jelic, 2019). Our EEG-
PET imaging study further suggests localization, that is, tem-
poroparietal cortex, and metabolic correlates, that is, associa-
tion with glucose hypometabolism, of the reported decrease
in EEG connectivity within fast frequencies. We emphasize
that localized measures of EEG instantaneous dependence in
both scalp and cortical source space should be interpreted
with caution since they are confounded by volume conduction
effect. However, they should not be completely disregarded
from EEG studies. Physiological zero-lag synchrony between
distant neuronal populations (cortical regions), as indicated
above, has been confirmed in several studies (Fell and
Axmacher, 2011; Traub et al., 1996; Vicente et al., 2008).
Therefore, EEG investigations that exclusively employ and in-
terpret lagged connectivity measures in the cortical source
space overlook a significant portion of a physiologically mean-
ingful zero-lag functional connectivity, whose disturbances in
patients along AD continuum have already been thoroughly
reported.
We further reported association between decreased brain
glucose metabolism and increased EEG-lagged linear connec-
tivity in slow frequency bands (delta and theta) in temporopar-
ietal lobes in MCI and AD patients. Several EEG LORETA
studies have described increase in lagged connectivity in
slow frequency bands in patients along AD continuum. These
alterations were most pronounced in temporal and frontal con-
nections in theta (Canuet et al., 2012) and in widespread con-
nections in delta band (Babiloni et al., 2018a). In addition,
abnormal lagged connectivity in theta band was shown to cor-
relate with cognitive decline, while increase in lagged connec-
tivity in delta band differentiated well between AD, Parkinson’s
disease, and Lewy Body dementia patients (Babiloni et al.,
2018a; Canuet et al., 2012). Concurrently, increase in resting-
state EEG activity in slow frequencies is an abnormal feature
and a characteristic EEG finding in cognitively impaired pa-
tients (Jelic and Kowalski, 2009). Even though the origin of
delta and theta oscillations still remains speculative, several
deep brain structures such as thalamus and limbic system in-
cluding hippocampus, cingulate, and entorhinal cortex have
been suggested as plausible contributors to the cortical slow
frequency activity (Michel, 2009). The interpretation of EEG
connectivity disturbances within slow frequency ranges might
therefore involve both direct cortical ROIs and deep brain
structures.
There are several proposed mechanisms behind increased
functional connectivity in patients along AD continuum, in-
cluding compensatory responses to the dysfunction of memory
networks as well as synaptotoxicity and genuine neuronal fail-
ure due to the AD-related pathology (Canuet et al., 2012;
Sperling et al., 2010). Furthermore, preclinical studies have
pointed out that increased synchrony in cortical circuits in
AD may be related to reduced GABAergic inhibition rather
than increased excitatory transmission (Palop and Mucke,
2010). Since it was shown that activation of GABA pathways
increases glucose metabolism in the brain (Peyron et al., 1994),
we could further speculate that the association between re-
duced cortical glucose metabolism and increased functional
connectivity might be a result of dysfunction of inhibitory neu-
rons in AD.
Since EEG signals result from summated postsynaptic po-
tentials and changes in ionic conductance across the neuronal
membrane demand metabolic energy, a relationship between
brain electrical activity and glucose metabolism was somewhat
expected. In addition, the role of brain glucose hypometabo-
lism, evidenced by [18F]FDG-PET, as a marker of synaptic
function was substantiated by several studies. First, resting-
state glucose metabolism was found to correlate with synapto-
physin levels, presynaptic vesicle membrane protein, when
analyzed in the corresponding brain regions (Rocher et al.,
2003). Second, loss of synaptic density and activity leads to
the decrease in neuronal energy demand and consequent re-
duction in the brain glucose metabolism (Mosconi, 2005).
Third, recent studies provide evidence that [18F]FDG uptake
is not a mere marker of brain neuronal activity as it reflects
glucose uptake in astrocytes, important for synaptic function
and plasticity (Zimmer et al., 2017). The latter notion might
contribute to the part of variance not explained by the correla-
tions between cortical glucose metabolism and EEG measures.
Differences in methodological aspects of these techniques,
such as spatial and temporal resolutions, could further ratio-
nalize moderate correlations.
The main limitations of this study are the cross-sectional
design and a limited number of study participants. Even though
the association between [18F]FDG-PET and EEG connectivity
measures was not detected in the CSF amyloid-negative group,
it should be further investigated since the group consisted of
10 patients only. Furthermore, large-scale multicentric stud-
ies with longitudinal design would allow for stratification
of MCI patients on progressive (progressing to AD) and sta-
bile MCI patients and evaluation of diagnostic and prognos-
tic potential of EEG LORETA measures of brain functional
connectivity in the context of AD.
Conclusions
Our study demonstrated that topographical EEG measures
of functional connectivity may detect regional dysfunction of
AD-vulnerable brain areas as evidenced by association and
spatial overlap with the cortical glucose hypometabolism
in clinically diagnosed MCI and AD patients and in patients
with biomarker-verified AD pathology. Moreover, our results
indicate that EEG measures of both instantaneous and lagged
linear connectivity might provide comprehensive information
on regional cortical disconnection associated with AD. EEG
is a noninvasive and widely accessible diagnostic technique
that could have broad implication in clinical practice and AD
drug trials. Future large-scale longitudinal studies are required
to assess diagnostic and prognostic potential of topographical
EEG measures of brain functional connectivity in patients
along AD continuum.
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